FRCTX
Price
$6.77
Change
-$0.00 (-0.00%)
Updated
Nov 26 closing price
Net Assets
13.01B
TACAX
Price
$9.91
Change
+$0.01 (+0.10%)
Updated
Nov 26 closing price
Net Assets
540.26M
Interact to see
Advertisement

FRCTX vs TACAX

Header iconFRCTX vs TACAX Comparison
Open Charts FRCTX vs TACAXBanner chart's image
Franklin CA Tax Free Income C
Price$6.77
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets13.01B
JHancock CA Municipal Bond A
Price$9.91
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets540.26M
FRCTX vs TACAX Comparison Chart in %
View a ticker or compare two or three
VS
FRCTX vs. TACAX commentary
Nov 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRCTX is a Hold and TACAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FRCTX has more cash in the bank: 13B vs. TACAX (540M). TACAX pays higher dividends than FRCTX: TACAX (3.66) vs FRCTX (3.18). FRCTX was incepted earlier than TACAX: FRCTX (31 years) vs TACAX (36 years). FRCTX (1.16) is less costly to investors than TACAX (0.87). TACAX is a more actively managed with annual turnover of: 42.00 vs. FRCTX (7.96). FRCTX (1000) and TACAX (1000) have matching initial minimum investment requirements. FRCTX annual gain was more profitable for investors over the last year : 1.34 vs. TACAX (1.03). TACAX return over 5 years is better than : 6.05 vs. FRCTX (-2.79).
FRCTXTACAXFRCTX / TACAX
Total Expense Ratio1.160.72161%
Annual Report Gross Expense Ratio1.160.87133%
Fund Existence31 years36 years-
Gain YTD2.1571.869115%
Front LoadN/A4%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets13B540M2,407%
Annual Yield % from dividends3.183.6687%
Returns for 1 year1.341.03129%
Returns for 3 years10.7113.6678%
Returns for 5 years-2.796.05-46%
Returns for 10 years4.3325.1017%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BIB83.581.47
+1.79%
ProShares Ultra Nasdaq Biotechnology
SPXX17.770.24
+1.37%
Nuveen S&P 500 Dynamic Overwrite Fund
MLPD25.220.13
+0.52%
Global X MLP & Engy Infras Cov Cll ETF
CLM8.270.04
+0.49%
Cornerstone Strategic Value Fund
BMED30.930.10
+0.34%
iShares Health Innovation Active ETF